Hjem › Alopecia areata › Texas
Alopecia areata kliniske forsøg i Texas
7 studier for Alopecia areata søger deltagere på steder i Texas.
Byer i Texas
Officiel studietekst (engelsk)
A Study to Evaluate the Safety and Effectiveness of Upadacitinib in Pediatric Participants With Alopecia Areata
- 3A Research - East location /ID# 283404, El Paso
- Texas Dermatology and Laser Specialists /ID# 282813, San Antonio
RekruttererFase 3
Alder 6 til 17 · Alle køn · Opdateret 2. okt. 2026 · NCT07772492A Study of LY4005130 in Adult Participants With Severe Alopecia Areata (Hair Loss)
- Texas Dermatology and Laser Specialists - San Antonio - South New Braunfels Avenue, San Antonio
RekruttererFase 2
Alder 18 til 50 · Alle køn · Opdateret 22. sep. 2026 · NCT07533006A Study of 2 Doses of Ritlecitinib in People 12 Years of Age and Older With Alopecia Areata
- The University of Texas Health Science Center at Houston, Bellaire
- Center for Clinical Studies, Houston
- Center for Clinical Studies - Clear Lake, Webster
RekruttererFase 3
Alder 12 og opefter · Alle køn · Opdateret 18. sep. 2026 · NCT06873945A Study in Young People and Adults to Learn About the Medicine Ritlecitinib for Treatment of Patchy Hair Loss, Known by the Medical Term as Moderate Alopecia Areata
- Center for Clinical Studies, LTD. LLP, Houston
- Texas Dermatology and Laser Specialists, San Antonio
RekruttererFase 3
Alder 12 og opefter · Alle køn · Opdateret 10. sep. 2026 · NCT07733765A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants With Severe Alopecia Areata
- Arlington Research Center, Inc /ID# 258028, Arlington
- Bellaire Dermatology Associates /ID# 259360, Bellaire
- Dfw Clinical Trials /ID# 284604, Carrollton
- og 5 flere
RekruttererFase 3
Alder 12 til 63 · Alle køn · Opdateret 3. aug. 2026 · NCT06012240A Long-Term Study to Learn About The Study Medicine Called Ritlecitinib in Children With Severe Alopecia Areata.
- 3A Research, El Paso
- Texas Dermatology and Laser Specialists, San Antonio
RekruttererFase 3
Alder 6 til 14 · Alle køn · Opdateret 28. apr. 2026 · NCT07029828Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescents With Severe Alopecia Areata
- Dermatology Treatment And Research Center - Dallas, Dallas
- North Texas Center For Clinical Research, Frisco
- Austin Institute For Clinical Research Inc., Pflugerville
- og 1 flere
RekruttererFase 3
Alder 12 til 17 · Alle køn · Opdateret 28. jan. 2026 · NCT07133308Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.